AI Article Synopsis

  • The study explores the potential of umbilical cord matrix mesenchymal stem cells (UCM-MSCs) for therapeutic uses, specifically their differentiation into bone (osteogenic) and nerve (neurogenic) cells when influenced by the calcium-sensing receptor (CaSR).
  • The research involved large and small equine UCM-MSC lines cultured in calcium-enriched mediums and treated with a CaSR agonist, AMG641, which showed a dose-dependent increase in cell proliferation and varying effects on osteogenic marker expression.
  • Findings suggest that AMG641 can enhance neurogenic differentiation and that CaSR plays a critical role in regulating the differentiation processes of these stem cells.

Article Abstract

Background: Umbilical cord matrix mesenchymal stem cells (UCM-MSCs) present a wide range of potential therapeutical applications. The extracellular calcium-sensing receptor (CaSR) regulates physiological and pathological processes. We investigated, in a large animal model, the involvement of CaSR in triggering osteogenic and neurogenic differentiation of two size-sieved UCM-MSC lines, by using AMG641, a novel potent research calcimimetic acting as CaSR agonist.

Methodology/principal Findings: Large (>8 µm in diameter) and small (<8 µm) equine UCM-MSC lines were cultured in medium with high calcium (Ca2+) concentration ([Ca2+]o; 2.87 mM) and dose-response effects of AMG641 (0.01 to 3µM) on cell proliferation were evaluated. Both cell lines were then cultured in osteogenic or neurogenic differentiation medium containing: 1) low [Ca2+]o (0.37 mM); 2) high [Ca2+]o (2.87 mM); 3) AMG641 (0.05, 0.1 or 1 µM) with high [Ca2+]o and 4) the CaSR antagonist NPS2390 (10 mM for 30 min) followed by incubation with AMG641 in high [Ca2+]o. Expression of osteogenic or neurogenic differentiation biomarkers was compared among groups. In both cell lines, AMG641 dose-dependently increased cell proliferation (up to P<0.001). Osteogenic molecular markers expression was differentially regulated by AMG641, with stimulatory (OPN up-regulation) in large or inhibitory (RUNX2 and OPN down-regulation) effects in small cells, respectively. AMG641 significantly increased alkaline phosphatase activity and calcium phosphate deposition in both cell lines. Following treatment with AMG641 during osteogenic differentiation, in both cell lines CaSR expression was inversely related to that of osteogenic markers and inhibition of CaSR by NPS2390 blocked AMG641-dependent responses. Early-stage neurogenic differentiation was promoted/triggered by AMG641 in both cell lines, as Nestin and CaSR mRNA transcription up-regulation were observed.

Conclusions/significance: Calcium- and AMG641-induced CaSR stimulation promoted in vitro proliferation and osteogenic and early-stage neurogenic differentiation of UCM-MSCs. CaSR activation may play a fundamental role in selecting specific differentiation checkpoints of these two differentiation routes, as related to cell commitment status.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224416PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0111533PLOS

Publication Analysis

Top Keywords

neurogenic differentiation
8
umbilical cord
8
cord matrix
8
matrix mesenchymal
8
mesenchymal stem
8
stem cells
8
large animal
8
animal model
8
calcium-sensing receptor-mediated
4
receptor-mediated osteogenic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!